Loading…

Fagron, a global pharmaceutical compounding company, announced that Brazilian competition authority CADE has granted clearance for the acquisitions of Purifarma and Injeplast in Brazil. The transactions will broaden Fagron's portfolio and capabilities in Brazil.
“CADE's approvals allow us to progress towards closing Purifarma and Injeplast.”menafn.com
Summarized from public sources; check the original articles before acting on it.